Disease/Infection News

RSS

Quest Diagnostics' Simplexa Influenza A H1N1 (2009) test receives CE mark

Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, today announced that the Simplexa Influenza A H1N1 (2009) test developed by its Focus Diagnostics business has been CE marked and is now available as a test kit for distribution to approximately 35 countries in Europe.

From Quest Diagnostics 18 Nov 2009

ED clinicians utilize WEBeMARS to report the progress of the H1N1 flu pandemic

EDIMS LLC, a leading provider of interoperable emergency department (ED) information management systems for hospitals, announced today that 22 of its client EDs in New York and New Jersey are reporting daily on the progress of the H1N1 flu pandemic to their state health departments.

18 Nov 2009

Previous flu infections can reduce the severity of H1N1

Researchers at the La Jolla Institute for Allergy & Immunology have found that previous influenza infections may provide at least some level of immunity to the H1N1 "swine" flu. "The question we asked was, "Is the swine flu more like the seasonal flu or like a totally new strain of influenza where there would be no immunity?," said Alessandro Sette, Ph.D., an internationally recognized vaccine expert and director of the La Jolla Institute's Center for Infectious Disease.

18 Nov 2009

Cinergy Health creates a guide for the prevention and treatment of H1N1

Cinergy Health, a nationwide provider of guaranteed issue health insurance benefit programs, has created a guide for consumers concerned about the H1N1 virus, which has already killed more than 4,000 Americans.

18 Nov 2009

Tips on how to prevent household members from getting sick during flu season

someone at home who has H1N1 (swine) flu, it is important for you to prevent other people in the house from getting sick, according to Gary Kalkut, MD, MPH, Senior Vice-President, Chief Medical Officer of Montefiore Medical Center.

18 Nov 2009

Global Alliance for Chronic Diseases announces targets

The Global Alliance for Chronic Diseases (GACD) on Monday outlined plans "to invest tens of millions of dollars in heart and lung disease studies in a battle against a global epidemic of chronic disease," over five years, Reuters reports.

17 Nov 2009

China, WHO to collaborate on flu research center

Chinese and WHO officials last week agreed to open a flu research center in Beijing, Bloomberg reports. "The new collaborating center for reference and research on influenza will join a network of WHO-affiliated labs in Atlanta, London, Tokyo and Melbourne that monitor flu strains and make recommendations on vaccines to fight the virus," the news service writes

17 Nov 2009

KHN column: Is fear of flu shifting the goal posts?

"If any public health message has alarmed Americans in recent weeks, it is the repeated claim in the media that healthy young people are dying of 2009 H1N1, or swine flu. ... The response has been predictable: frantic parents clogging waiting rooms in pediatricians' offices, lining up for hours to get their kids vaccinated, and rushing to fill prescriptions for anti-viral drugs before the local pharmacy runs out" (11/17).

17 Nov 2009

AIDS advocates ask White House to send money south

WLBT: "The White House Office of National AIDS Policy chose Jackson [Mississipppi] to host an HIV/AIDS town hall meeting Monday night. The community discussion allowed Mississippians to give feedback that will be included in a national strategy to end the HIV/AIDS epidemic. ... Many asked for sex and STD education in the schools, more doctors and transportation funding in rural areas and health insurance" (Anderson, 11/17).

17 Nov 2009

Bavarian Nordic awarded a new contract for developing a freeze-dried version of its IMVAMUNE smallpox vaccine

Bavarian Nordic A/S announced today that BARDA (Biomedical Advanced Research and Development Authority) has awarded a new contract to Bavarian Nordic for the development of a freeze-dried version of its IMVAMUNE(R) smallpox vaccine with a total prospective value of USD 40 million.

17 Nov 2009

Anacor Pharmaceuticals commences patient dosing in AN3365 Phase I clinical study

Anacor Pharmaceuticals today announced that it has dosed the first patient in a Phase I clinical study for AN3365, a novel boron-based, small-molecule drug candidate in development for the treatment of hospital infections caused by Gram-negative bacteria. The study will evaluate the safety, tolerability and pharmacokinetics of AN3365 in healthy volunteers.

17 Nov 2009

Go Travel Insurance urge gap year travellers to take out proper cover for swine flu

As swine flu threatens to make a resurgence, Go Travel Insurance have reinforced the need for gap year students to take out proper cover before they embark on their trip.

17 Nov 2009

Business professors available for expert commentary on how PPPs can help fight HIV/AIDS

The following professors from the University of Virginia's Darden School of Business are available for expert commentary on how public-private partnerships (PPPs) can help win the fight against HIV/AIDS in cities throughout the United States.

17 Nov 2009

Researchers study different plant substances to "awaken" the latent HIV-1 virus

Researchers from the University of Cadiz and the University of Cordoba study different plant substances to "awaken" the latent HIV-1 virus, immune to the current therapy, and to obtain more effective treatments in the future.

17 Nov 2009

Total of 1,686,100 doses of H1N1 vaccine allocated to Pennsylvania to date: Department of Health

The federal Centers for Disease Control and Prevention, or CDC, has allocated a total of 1,686,100 doses of H1N1 vaccine to Pennsylvania to date, the Department of Health said today.

17 Nov 2009

Power of prevention in women's hands: NYC scales up access to the second-generation female condom

African Services Committee is praising New York City's Department of Health, for showing national leadership in putting the second-generation female condom into the hands of women living with or at risk of HIV/AIDS infection.

17 Nov 2009

Molecular makeup of current H1N1 flu strain strikingly different from previous H1N1 strains

As the number of deaths related to the pandemic H1N1 virus, commonly known as "swine flu," continues to rise, researchers have been scrambling to decipher its inner workings and explain why the incidence is lower than expected in older adults.

17 Nov 2009

CD4 Initiative selects Zyomyx's CD4 POC technology as best for measuring CD4 T-cell count in HIV/AIDS patients

Zyomyx, Inc., a leader in chip-based bioanalysis technologies, today announced that its readerless CD4 point-of-care (POC) technology was selected by Imperial College London's CD4 Initiative as the best-performing POC test method for measuring CD4 T-cell count in HIV/AIDS patients. Zyomyx's CD4 assay is now the only remaining POC product being supported by the CD4 Initiative.

17 Nov 2009

Economic crisis impacts health department capacity to address rising STD rates

Amid the mounting toll of budget cuts across the country, a new study from the National Coalition of STD Directors (NCSD) shows just how much an impact the economic crisis is having on sexually transmitted disease (STD) programs and in turn, having more broadly on public health infrastructure.

17 Nov 2009

Trustmark Voluntary Benefit Solutions offers coverage for vaccines including H1N1 to its policyholders

Trustmark Voluntary Benefit Solutions, a leading provider of payroll-deducted voluntary benefits, is now covering vaccines including H1N1 (swine flu).

17 Nov 2009

Disease/Infection News

Quest Diagnostics' Simplexa Influenza A H1N1 (2009) test receives CE mark

ED clinicians utilize WEBeMARS to report the progress of the H1N1 flu pandemic

Previous flu infections can reduce the severity of H1N1

Cinergy Health creates a guide for the prevention and treatment of H1N1

Tips on how to prevent household members from getting sick during flu season

Global Alliance for Chronic Diseases announces targets

China, WHO to collaborate on flu research center

KHN column: Is fear of flu shifting the goal posts?

AIDS advocates ask White House to send money south

Bavarian Nordic awarded a new contract for developing a freeze-dried version of its IMVAMUNE smallpox vaccine

Anacor Pharmaceuticals commences patient dosing in AN3365 Phase I clinical study

Go Travel Insurance urge gap year travellers to take out proper cover for swine flu

Business professors available for expert commentary on how PPPs can help fight HIV/AIDS

Researchers study different plant substances to "awaken" the latent HIV-1 virus

Total of 1,686,100 doses of H1N1 vaccine allocated to Pennsylvania to date: Department of Health

Power of prevention in women's hands: NYC scales up access to the second-generation female condom

Molecular makeup of current H1N1 flu strain strikingly different from previous H1N1 strains

CD4 Initiative selects Zyomyx's CD4 POC technology as best for measuring CD4 T-cell count in HIV/AIDS patients

Economic crisis impacts health department capacity to address rising STD rates

Trustmark Voluntary Benefit Solutions offers coverage for vaccines including H1N1 to its policyholders

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Latest News